New Method Decreases the Cost of Single-Cell Sequencing; Frees Up Resources to Analyze More Cells SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )--In a paper published in Nature Biotechnology this week, UC San Francisco and Fluidigm Corporation (NASDAQ:FLDM) scientists have demonstrated that
SOUTH SAN FRANCISCO, Calif., July 31, 2014 - Fluidigm Corporation (NASDAQ:FLDM) has begun accepting applications to an early access program for its upcoming imaging mass cytometry platform. Prototypes of the product are expected to begin shipping to early access partners by the end of this year.
SOUTH SAN FRANCISCO, Calif., July 23, 2014 — Fluidigm Corporation (NASDAQ:FLDM) will report its second quarter 2014 financial results on July 31, 2014, after close of market. Gajus Worthington, Fluidigm president and chief executive officer, and Vikram Jog, chief financial officer, will host a
Fluidigm Ships Flex six™ Integrated Fluidic Circuits to Genotyping and Gene Expression Customers SOUTH SAN FRANCISCO, Calif., June 3, 2014 — Fluidigm Corporation (NASDAQ:FLDM) has begun shipping production volumes of its Flex Six™ integrated fluidic circuits (IFCs) to genotyping and gene
Fluidigm to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference SOUTH SAN FRANCISCO, Calif. – May 6, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced that Chief Financial Officer Vikram Jog and Vice President of Corporate Development Un Kwon-Casado will present at the